SL
VRTX icon

Signition LP’s Vertex Pharmaceuticals VRTX Stock Holding History

Signition LP’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,217
Closed -$2.06M – 166
2019
Q2 		$2.06M Buy
11,217
+10,125
+927% +$1.77M 1.35% 26
2019
Q1 		$201K Buy
+1,092
New +$202K 0.14% 151
2018
Q2 		– Sell
-17,507
Closed -$2.85M – 316
2018
Q1 		$2.85M Buy
17,507
+526
+3% +$85.9K 3.47% 5
2017
Q4 		$2.54M Buy
+16,981
New +$2.51M 3.3% 7

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Signition LP's VRTX Position: Q3 2019 in Review

Signition LP sold out of Vertex Pharmaceuticals (VRTX) in Q3 2019, closing a stake of 11,217 shares — an estimated $2.06M sold.

Signition LP first reported a position in VRTX in Q4 2017 and held it in 4 quarters. The position peaked at $2.85M in Q1 2018. 707 funds tracked by Wall St. Rank hold VRTX as of Q3 2019.

  • Signition LP reported no remaining Vertex Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Signition LP sold 11,217 Vertex Pharmaceuticals shares in Q3 2019, an estimated $2.06M.
  • Signition LP first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • Signition LP's Vertex Pharmaceuticals position peaked at $2.85M in Q1 2018.
  • 707 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2019.

Based on Signition LP's 13F filing for Q3 2019, filed 5 Nov 2019.